Table 2. Expression of genes involved in cell cycle in LS-174T i.p. xenografts following treatment with Paclitaxel and 212Pb-trastuzumab.
Symbol | Gene name | GeneBank ID | Fold change | |||||
Paclitaxel-212Pb-trastuzumab | p | Paclitaxel-212Pb-HuIgG | p | Paclitaxel | p | |||
BRCA1 | Breast Cancer 1, early onset | NM_007294 | −3.8 | 0.0005 | −3.0 | 0.0022 | −2.1 | 0.0061 |
CHK1 | CHK1 checkpoint homolog | NM_001274 | −4.0 | 0.0001 | −3.2 | 0.0002 | −2.4 | 0.0018 |
CHK2 | CHK2 checkpoint homolog | NM_007194 | −2.0 | 0.0016 | −1.9 | 0.0025 | −2.4 | 0.0032 |
GADD45α | Growth arrest and DNA-damage-inducible, alpha | NM_001924 | 5.9 | 0.0001 | 3.8 | 0.0002 | 1.9 | 0.0962 |
GML | Glycosylphosphatidylinositol anchored molecule like protein | NM_002066 | 26.4 | 0.0004 | 2.7 | 0.0023 | −1.4 | 0.4430 |
GTSE1 | G-2 and S-phase expressed 1 | NM_016426 | −9.3 | 0.0014 | −4.3 | 0.0025 | −3.1 | 0.0043 |
NBN | Nibrin | NM_002485 | −2.0 | 0.0303 | −2.1 | 0.0065 | −1.4 | 0.0999 |
PCBP4 | Poly(rC)binding protein 2 | NM_020418 | 3.1 | 0.0116 | 2.8 | 0.0012 | 1.6 | 0.0205 |
PPP1R15A | Protein phosphatase 1, regulatory subunit 15A | NM_014330 | 2.6 | 0.0115 | 1.4 | 0.0399 | −1.1 | 0.4490 |
RAD9A | RAD9 homolog A | NM_004584 | 2.4 | 0.0016 | 1.6 | 0.0006 | −1.3 | 0.0132 |
SESN1 | Sestrin1 | NM_014454 | 4.6 | 0.0001 | 3.8 | 0.0006 | 2.8 | 0.0004 |